{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:47:46Z","timestamp":1783036066499,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jvacx.2022.100256","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T02:32:12Z","timestamp":1672194732000},"page":"100256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021\u20132030"],"prefix":"10.1016","volume":"13","author":[{"given":"Salin","family":"Sriudomporn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Yoon Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Hutubessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Patenaude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2022.100256_b0005","unstructured":"World Health Organization, \u201cImmunization Agenda 2030: A global strategy to leave no one behind,\u201d Apr. 2020."},{"key":"10.1016\/j.jvacx.2022.100256_b0010","series-title":"Implementing the immunization agenda 2030: A framework for action through coordinated planning, monitoring & evaluation, ownership & accountability, and communications & advocacy","first-page":"1","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.jvacx.2022.100256_b0015","first-page":"41","article-title":"Modeling the impact of vaccination for the Immunization Agenda 2030: Deaths Averted due to Vaccination against 14 Pathogens in 194 Countries from 2021\u201330","author":"Carter","year":"2021","journal-title":"SSRN"},{"key":"10.1016\/j.jvacx.2022.100256_b0020","unstructured":"World Health Organization, \u201cImmunization services begin slow recovery from COVID-19 disruptions, though millions of children remain at risk from deadly diseases \u2013 WHO, UNICEF, Gavi,\u201d Apr. 2021. ."},{"key":"10.1016\/j.jvacx.2022.100256_b0025","doi-asserted-by":"crossref","unstructured":"S. Y. Sim, E. Watts, D. Constenla, L. Brenzel, and B. N. Patenaude, \u201cReturn On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011\u201330,\u201d https:\/\/doi.org\/10.1377\/hlthaff.2020.00103, vol. 39, no. 8, pp. 1343\u20131353, Aug. 2020, doi: 10.1377\/HLTHAFF.2020.00103.","DOI":"10.1377\/hlthaff.2020.00103"},{"key":"10.1016\/j.jvacx.2022.100256_b0030","article-title":"to 2030\u201d","volume":"2021","author":"Sim","year":"2011","journal-title":"Value Heal"},{"key":"10.1016\/j.jvacx.2022.100256_b0035","unstructured":"World Health Organization, \u201cWHO Regional offices,\u201d 2021. ."},{"key":"10.1016\/j.jvacx.2022.100256_b0040","unstructured":"The World Bank, \u201cWorld Bank Country and Lending Groups,\u201d 2021. ."},{"key":"10.1016\/j.jvacx.2022.100256_b0045","unstructured":"The vaccine alliance Gavi, \u201cGavi Alliance Eligibility and Transition Policy,\u201d no. June. pp. 0\u20134, 2018, [Online]. Available: https:\/\/www.gavi.org\/sites\/default\/files\/document\/gavi-eligibility-and-transition-policypdf.pdf."},{"key":"10.1016\/j.jvacx.2022.100256_b0050","unstructured":"United Nations, \u201cWorld Population Prospects - Population Division - United Nations,\u201d 2019. ."},{"key":"10.1016\/j.jvacx.2022.100256_b0055","unstructured":"\u201cGavi detailed product profile (DPPs) for WHO prequalified vaccines.\u201d 2018, [Online]. Available: https:\/\/www.gavi.org\/our-alliance\/market-shaping\/product-information-vaccines-cold-chain-equipment."},{"key":"10.1016\/j.jvacx.2022.100256_b0060","series-title":"Vaccine Introduction Guidelines Adding a vaccine to a national immunization programme: decision and implementation WHO\/IVB\/05.18 ORIGINAL: ENGLISH Immunization, Vaccines and Biologicals","author":"World Health Organization","year":"2005"},{"key":"10.1016\/j.jvacx.2022.100256_b0065","unstructured":"Gavi the Vaccine Alliance, \u201cPublic Price Forecast.\u201d 2021."},{"key":"10.1016\/j.jvacx.2022.100256_b0070","unstructured":"Pan American Health Organization, \u201cPAHO Revolving Fund - PAHO\/WHO | Pan American Health Organization,\u201d 2021. ."},{"key":"10.1016\/j.jvacx.2022.100256_b0075","unstructured":"UNICEF, \u201cSupplies and Logistics: Vaccine Price Data.\u201d 2018."},{"key":"10.1016\/j.jvacx.2022.100256_b0080","unstructured":"\u201cGlobal Vaccine Market Report Overview of MI4A,\u201d 2019. [Online]. Available: http:\/\/apps.who.int\/gb\/ebwha\/."},{"key":"10.1016\/j.jvacx.2022.100256_b0085","unstructured":"\u201cImmunization schedules by antigens.\u201d 2020, [Online]. Available: https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules."},{"key":"10.1016\/j.jvacx.2022.100256_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s40273-020-00930-6","article-title":"Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates","author":"Portnoy","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jvacx.2022.100256_b0095","unstructured":"ThinkWell, \u201cImmunization Delivery Costs in Low-and Middle-Income Countries A descriptive analysis, gap analysis, and summary of immunization delivery unit costs in the literature,\u201d Washington, D.C., 2020."},{"key":"10.1016\/j.jvacx.2022.100256_b0100","unstructured":"World Health Organization, \u201cWHO-UNICEF Guidelines for Comprehensive Multi-Year Planning for Immunization Immunization, Vaccines and Biologicals,\u201d Geneva, Switzerland, 2014."},{"key":"10.1016\/j.jvacx.2022.100256_b0105","unstructured":"K. H. T. Yeung, K. Prem, A. Cook, M. Jit, and R. Hutubessy, \u201cHuman Papillomavirus Vaccine Delivery Cost Extrapolation in low-income and lower middle-income countries.\u201d ."},{"key":"10.1016\/j.jvacx.2022.100256_b0110","unstructured":"UNICEF, \u201cCosts of Vaccinating a Child,\u201d New York, NY, Aug. 2020."},{"issue":"25","key":"10.1016\/j.jvacx.2022.100256_b0115","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1016\/j.vaccine.2018.05.030","article-title":"Systematic review of the incremental costs of interventions that increase immunization coverage","volume":"36","author":"Ozawa","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2022.100256_b0120","first-page":"1","year":"2018","journal-title":"Organization"},{"key":"10.1016\/j.jvacx.2022.100256_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.07.068","article-title":"Expenditures on vaccine-preventable disease surveillance: Analysis and evaluation of comprehensive multi-year plans (cMYPs) for immunization","author":"Hossain","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2022.100256_b0130","article-title":"The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review","volume":"X","author":"Vaughan","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2022.100256_b0135","unstructured":"Immunization delivery costing consensus statement, \u201cImmunization Delivery Costing Consensus Statement,\u201d 2021."},{"key":"10.1016\/j.jvacx.2022.100256_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.07.038","article-title":"Vaccine preventable diseases surveillance in Nepal: How much does it cost?","author":"Huang","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2022.100256_b0145","unstructured":"UNICEF and World Health Organization, \u201cProgress and Challenges with Sustaining and Advancing Immunization Coverage during the COVID-19 Pandemic,\u201d Jul. 2021. ."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:06:53Z","timestamp":1762913213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136222001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":29,"alternative-id":["S2590136222001164"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100256","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021\u20132030","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100256"}}